ClassID:

96902

C07K14/4705 - page 2 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used; Regulators; Modulating activity stimulating, promoting or activating activity

Recent Application in this class:
#301
20190092824
2019-03-28

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#302
20190092821
2019-03-28

Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof

#303
20190071478
2019-03-07

Peptide having hair growth-promoting activity and/or melanin generation-promoting activity, and use thereof

#304
20190062837
2019-02-28

Screening method

#305
20190031735
2019-01-31

VEGF antagonist formulations suitable for intravitreal administration

#306
20190023755
2019-01-24

Compositions and methods of using islet neogenesis peptides and analogs thereof

#307
20190023754
2019-01-24

Stabilized BCL9 peptides for treatment of aberrant WNT signaling

#308
20190016751
2019-01-17

Compositions and methods directed to treating liver fibrosis

#309
20190010531
2019-01-10

CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN

#310
20190010197
2019-01-10

Method using expression of LIN28 for preparing stem cells having excellent renewal ability and therapeutic capacity

#311
20180371456
2018-12-27

ATP-binding cassette family coding polyribonucleotides and formulations thereof

#312
20180371051
2018-12-27

NKG2D decoys

#313
20180369338
2018-12-27

TREATING CARDIOVASCULAR OR RENAL DISEASES

#314
20180362603
2018-12-20

Methods and compositions for reducing the immunogenicity of chimeric notch receptors

#315
20180360995
2018-12-20

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES

#316
20180346538
2018-12-06

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#317
20180346512
2018-12-06

FOXM1-derived peptide, and vaccine including same

#318
20180312557
2018-11-01

Leg1 Protein, Leg1 Gene, and Uses and Drugs thereof

#319
20180311381
2018-11-01

Modified Polynucleotides for the production of biologics and proteins associated with human disease

#320
20180311343
2018-11-01

MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF

#321
20180298070
2018-10-18

Peptide compound

#322
20180298069
2018-10-18

Cell lines for screening odorant and aroma receptors

#323
20180292395
2018-10-11

Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin

#324
20180291370
2018-10-11

High-throughput screening of regulatory element function with epigenome editing technologies

#325
20180273595
2018-09-27

ERG targeted therapy

#326
20180271945
2018-09-27

UROCORTIN 2 ANALOGS AND USES THEREOF

#327
20180271941
2018-09-27

Methods for modulating development and function of photoreceptor cells

#328
20180251506
2018-09-06

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#329
20180245038
2018-08-30

METHOD FOR GENERATING SOMATIC STEM CELLS

#330
20180237499
2018-08-23

Cell-penetrating ATF5 polypeptides and uses thereof

#331
20180230190
2018-08-16

FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS

#332
20180216079
2018-08-02

Generation of human iPS cells by a synthetic self-replicative RNA

#333
20180187211
2018-07-05

Methods and compositions for combination immunotherapy

#334
20180187188
2018-07-05

Cancer specific-splicing ribozyme and use thereof

#335
20180179527
2018-06-28

Modulation of BCL11A for treatment of hemoglobinopathies

#336
20180170985
2018-06-21

CRISPR-based methods and products for increasing frataxin levels and uses thereof

#337
20180164286
2018-06-14

Cell-based assay for determining mTOR activity

#338
20180155408
2018-06-07

VEGF antagonist formulations suitable for intravitreal administration

#339
20180153993
2018-06-07

COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES

#340
20180134759
2018-05-17

METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS

#341
20180119143
2018-05-03

Therapeutic methods, products and compositions inhibiting ZNF555

#342
20180111994
2018-04-26

LINGO-2 ANTAGONISTS FOR TREATMENT OF CONDITIONS INVOLVING MOTOR NEURONS

#343
20180105565
2018-04-19

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#344
20180105564
2018-04-19

USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS

#345
20180105563
2018-04-19

Agent for prevention or treatement of corneal disorders

#346
20180104307
2018-04-19

Targeting GIV-GEF-GI signaling for treating diverse diseases

#347
20180100158
2018-04-12

Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same

#348
20180100016
2018-04-12

USE OF CAR-MODIFIED HUMAN NATURAL KILLER CELLS TO TREAT CANCER

#349
20180100002
2018-04-12

Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis

#350
20180072785
2018-03-15

Peptide for inducing regeneration of tissue and use thereof

#351
20180066032
2018-03-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS

#352
20180066030
2018-03-08

Method of treating vitiligo using mutant HSP70i

#353
20180057550
2018-03-01

Methods and compositions for regenerating tissues

#354
20180037620
2018-02-08

Genetically modified pig cells with an inactivated Etv2 gene

#355
20180030110
2018-02-01

Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein

#356
20180023062
2018-01-25

Compositions and methods for custom site-specific DNA recombinases

#357
20180016318
2018-01-18

Fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease

#358
20180009861
2018-01-11

COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF

#359
20180002389
2018-01-04

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#360
20170368200
2017-12-28

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#361
20170360886
2017-12-21

Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide

#362
20170354688
2017-12-14

Therapeutic effects of NURR1 and FOXA2 in inflammatory neurologic disorders by M1-to-M2 polarization of glial cells

#363
20170348436
2017-12-07

In vivo production of proteins

#364
20170342434
2017-11-30

Chloroplast Expressing Colostrum or Milk Polypeptides

#365
20170335008
2017-11-23

Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases

#366
20170306351
2017-10-26

Engineering a heterogeneous tissue from pluripotent stem cells

#367
20170299576
2017-10-19

PEPTIDOMIMETIC MACROCYCLES

#368
20170296653
2017-10-19

Methods of lowering serum cholesterol

#369
20170291938
2017-10-12

Production cell line enhancers

#370
20170240606
2017-08-24

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#371
20170240605
2017-08-24

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#372
20170233444
2017-08-17

RTEF-1 VARIANTS AND USES THEREOF

#373
20170232076
2017-08-17

Mannose-6-phosphate bearing peptides fused to lysosomal enzymes

#374
20170224779
2017-08-10

Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone

#375
20170219591
2017-08-03

PANCREATIC CANCER TARGETS AND USES THEREOF

#376
20170218037
2017-08-03

Compositions and methods for treatment of muscular dystrophy

#377
20170204148
2017-07-20

PEPTIDE-BASED STAT INHIBITOR

#378
20170189450
2017-07-06

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

#379
20170183392
2017-06-29

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

#380
20170173124
2017-06-22

Method for treating adenosine deaminase severe combined imunodeficiency

#381
20170166877
2017-06-15

DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

#382
20170152513
2017-06-01

Modulation of BCL11A for treatment of hemoglobinopathies

#383
20170152296
2017-06-01

COMPOSITIONS FOR THE TREATMENT OF WOUNDS

#384
20170114105
2017-04-27

Transcription activator-like effectors

#385
20170073382
2017-03-16

Methods and compositions for the packaging of nucleic acids into microglial exosomes for the targeted expression of polypeptides in neural cells

#386
20170067873
2017-03-09

Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays

#387
20170067081
2017-03-09

NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES

#388
20170067050
2017-03-09

RNA-interference by single-stranded RNA molecules

#389
20170066799
2017-03-09

Stitched polypeptides

#390
20170049854
2017-02-23

Methods for treating myocardial infarction comprising administering sonic hedgehog

#391
20170037110
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#392
20170037107
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#393
20170037098
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#394
20170037097
2017-02-09

Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers

#395
20170037096
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#396
20170037095
2017-02-09

Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide

#397
20170037094
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#398
20170037093
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#399
20170037092
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#400
20170035866
2017-02-09

Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment

#401
20170029487
2017-02-02

Selective inhibitors of c-Fos and their antiproliferative properties

#402
20170002321
2017-01-05

Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters

#403
20170002049
2017-01-05

Compositions and methods of using islet neogenesis peptides and analogs thereof

#404
20160376334
2016-12-29

Positive modulator of bone morphogenic protein-2

#405
20160369291
2016-12-22

Colostrum/milk protein compositions

#406
20160355559
2016-12-08

Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema

#407
20160319281
2016-11-03

Multiplex guide RNAs

#408
20160304598
2016-10-20

Production cell line enhancers

#409
20160280761
2016-09-29

Human leucine zipper/trail recombinant polypeptides

#410
20160257730
2016-09-08

Chloroplast expressing colostrum or milk polypeptides

#411
20160252523
2016-09-01

Method for removing genomically unstable IPS cells and synthetic peptide used therefor

#412
20160251386
2016-09-01

Lipid co-factor essential for cell density signaling

#413
20160244505
2016-08-25

VEGF antagonist formulations suitable for intravitreal administration

#414
20160244494
2016-08-25

STABILIZED POLYPEPTIDES AND USES THEREOF

#415
20160243251
2016-08-25

Artificial transcription factors comprising a sliding domain and uses thereof

#416
20160213765
2016-07-28

PLIF multimeric peptides and uses thereof

#417
20160213608
2016-07-28

VEGF antagonist formulations suitable for intravitreal administration

#418
20160200784
2016-07-14

FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS

#419
20160200783
2016-07-14

USE OF MULTIVALENT SYNTHETIC LIGANDS OF SURFACE NUCLEOLIN FOR TREATING CANCER OR INFLAMMATION

#420
20160194366
2016-07-07

APPLICATIONS OF AN IMMUNE SYSTEM-RELEASED ACTIVATING AGENT (ISRAA)

#421
20160159873
2016-06-09

RESEARCH BIO-NANOPARTICLE ELEMENTS AND PLATFORMS

#422
20160158385
2016-06-09

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#423
20160152947
2016-06-02

R-spondin variants, compositions, and methods of use

#424
20160152672
2016-06-02

Reagents and methods for treating dental disease

#425
20160151516
2016-06-02

Modified polynucleotides for the production of proteins

#426
20160122406
2016-05-05

ANALOGS OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND METHODS FOR THEIR USE

#427
20160115443
2016-04-28

VP16-CREB fusion gene

#428
20160115240
2016-04-28

Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency

#429
20160114017
2016-04-28

Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions

#430
20160109452
2016-04-21

Lung cancer biomarker

#431
20160102127
2016-04-14

TARGETED MODULATION OF MACROPHAGES

#432
20160096873
2016-04-07

PEPTIDOMIMETIC MACROCYCLES

#433
20160084852
2016-03-24

METHODS OF DETERMINATION OF ACTIVATION OR INACTIVATION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AND BRAIN NATRIURETIC PEPTIDE (BNP) HORMONAL SYSTEMS

#434
20160075733
2016-03-17

Modified polynucleotides for the production of biologics and proteins associated with human disease

#435
20160046700
2016-02-18

Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12

#436
20160046686
2016-02-18

COMPOSITIONS AND METHODS FOR INHIBITING TUMOR CELLS BY INHIBITING THE TRANSCRIPTION FACTOR ATF5

#437
20160038567
2016-02-11

EIF4E binding peptides

#438
20160015783
2016-01-21

Methods for modulating development and function of photoreceptor cells

#439
20150376648
2015-12-31

In vivo production of proteins

#440
20150376627
2015-12-31

Inducible Expression System Transcription Modulators Comprising A Distributed Protein Transduction Domain And Methods For Using The Same

#441
20150353634
2015-12-10

Production cell line enhancers

#442
20150353615
2015-12-10

Positive modulator of bone morphogenic protein-2

#443
20150352182
2015-12-10

Methods for treating myocardial infarction comprising administering sonic hedgehog

#444
20150337022
2015-11-26

Sequence of nucleotides and peptides GSE 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof

#445
20150315257
2015-11-05

Urocortin 2 analogs and uses thereof

#446
20150313961
2015-11-05

Materials and Methods for Regulating Whole Body Glucose Homeostasis

#447
20150291562
2015-10-15

IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#448
20150284438
2015-10-08

DOSAGE REGIME OF FUSION COMPOUNDS

#449
20150284437
2015-10-08

BETA-CATENIN TARGETING PEPTIDES AND USES THEREOF

#450
20150266926
2015-09-24

Small molecule polypeptide for inhibiting inflammation

#451
20150252074
2015-09-10

Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes

#452
20150239935
2015-08-27

Hydrogen bond surrogate macrocycles as modulators of Ras

#453
20150225469
2015-08-13

Method for regulating cell proliferation

#454
20150218242
2015-08-06

TIF1-Gamma for Treating and Diagnosing Inflammatory Diseases

#455
20150209407
2015-07-30

METHODS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND BONE-RELATED DISEASES

#456
20150202230
2015-07-23

LAT adapter molecule for enhanced T-cell signaling and method of use

#457
20150175688
2015-06-25

Production cell line enhancers

#458
20150175660
2015-06-25

Controlled modulation of amino acid side chain length of peptide antigens

#459
20150166616
2015-06-18

Modified polynucleotides for the production of cosmetic proteins and peptides

#460
20150159143
2015-06-11

Generation of human iPS cells by a synthetic self-replicative RNA

#461
20150139956
2015-05-21

Compositions which regulate the epithelial brush border Na/H exchanger NHE3 and their methods of use in gastrointestinal disease

#462
20150133389
2015-05-14

Methods of treatment of cancer using SRC-modulating peptides

#463
20150125918
2015-05-07

Acid-resistance in by engineering transcriptional factor

#464
20150118241
2015-04-30

LINGO-2 antagonists for treatment of conditions involving motor neurons

#465
20150111957
2015-04-23

Endothelial cell-specific polynucleotides and use thereof

#466
20150111946
2015-04-23

Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders

#467
20150111822
2015-04-23

WNT7A compositions and method of using the same

#468
20150111294
2015-04-23

Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters

#469
20150096066
2015-04-02

Target molecules for transcriptional control systems

#470
20150096064
2015-04-02

RNA-interference by single-stranded RNA molecules

#471
20150065435
2015-03-05

Reagents and methods for treating dental disease

#472
20150064236
2015-03-05

Modified polynucleotides for the production of proteins

#473
20150031622
2015-01-29

RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE

#474
20150030656
2015-01-29

Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis

#475
20150026831
2015-01-22

TL1A model of inflammation fibrosis and autoimmunity

#476
20150005371
2015-01-01

Treating cardiovascular or renal diseases

#477
20140377868
2014-12-25

RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci

#478
20140357840
2014-12-04

Method for obtaining a dialyzable leukocyte extract

#479
20140357704
2014-12-04

RTEF-1 variants and uses thereof

#480
20140341935
2014-11-20

MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE

#481
20140341877
2014-11-20

MCPIP as wound therapy

#482
20140328831
2014-11-06

SINGLE DOMAIN TDF-RELATED COMPOUNDS AND ANALOGS THEREOF

#483
20140323983
2014-10-30

VEGF antagonist formulations for intravitreal administration

#484
20140315753
2014-10-23

Engineering a heterogeneous tissue from pluripotent stem cells

#485
20140249208
2014-09-04

Modified polynucleotides for treating protein deficiency

#486
20140237630
2014-08-21

Screening method

#487
20140234969
2014-08-21

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

#488
20140234256
2014-08-21

Commensal bacteria as singal mediators within a mammalian host

#489
20140221465
2014-08-07

Modified polynucleotides for treating galactosylceramidase protein deficiency

#490
20140206619
2014-07-24

Peptide for inducing regeneration of tissue and use thereof

#491
20140200262
2014-07-17

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#492
20140199371
2014-07-17

Modified polynucleotides encoding basic helix-loop-helix family member E41

#493
20140193915
2014-07-10

Compositions and methods for custom site-specific DNA recombinases

#494
20140186432
2014-07-03

Modified polynucleotides encoding citeD4

#495
20140162952
2014-06-12

ERAP1-derived peptide and use thereof

#496
20140161873
2014-06-12

Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator

#497
20140155474
2014-06-05

MODIFIED POLYNUCLEOTIDES FOR TREATING CYSTIC FIBROSIS

#498
20140147432
2014-05-29

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#499
20140141067
2014-05-22

Modified polynucleotides encoding septin-4

#500
20140113960
2014-04-24

Modified polynucleotides encoding granulysin

#501
20140107189
2014-04-17

Modified polynucleotides encoding apoptosis inducing factor 1

#502
20140105966
2014-04-17

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

#503
20140105965
2014-04-17

Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1

#504
20140105964
2014-04-17

Modified polynucleotides encoding aquaporin-5

#505
20140087468
2014-03-27

Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters

#506
20140057804
2014-02-27

Cell model and method for screening c-Fms kinase inhibitors

#507
20140051647
2014-02-20

Synthetic peptide that induces expression of TNF receptor 2 and use thereof

#508
20140045769
2014-02-13

Hydrogen bond surrogate macrocycles as modulators of Ras

#509
20140045766
2014-02-13

Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same

#510
20130288948
2013-10-31

Establishment of motif comprising acidic amino acid, capable of stabilizing protein in cells, and applicable to protein therapy, control of differentiation/undifferentiation of cell and antibody therapy

#511
20130280763
2013-10-24

Archease as RNA ligaes complex member

#512
20130274189
2013-10-17

VEGF antagonist formulations for intravitreal administration

#513
20130259924
2013-10-03

Modified polynucleotides for the production of biologics and proteins associated with human disease

#514
20130259923
2013-10-03

Modified polynucleotides for the production of secreted proteins

#515
20130217864
2013-08-22

Human interleukin-1 receptor antagonist—hybrid Fc fusion protein

#516
20130205421
2013-08-08

Plant transactivation interaction motifs and uses thereof

#517
20130183318
2013-07-18

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

#518
20130171124
2013-07-04

Compositions and methods of treating head and neck cancer

#519
20130158097
2013-06-20

Compositions and methods directed to treating liver fibrosis

#520
20130157953
2013-06-20

TREATMENT OF CARDIAC CONDITIONS

#521
20130150294
2013-06-13

Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases

#522
20130149309
2013-06-13

Regulatory proteins and inhibitors

#523
20130139274
2013-05-30

B-cell stimulating fusion proteins of an antigen with BAFF or APRIL

#524
20130137633
2013-05-30

Methods Relating to Mammalian Rictor Polypeptide

#525
20130130989
2013-05-23

eIF4E binding peptides

#526
20130129629
2013-05-23

Modulation of BCL11A for treatment of hemoglobinopathies

#527
20130123122
2013-05-16

Tango 240 nucleic acids and uses thereof

#528
20130095475
2013-04-18

Genes from 20q13 amplicon and their uses

#529
20130065310
2013-03-14

USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS

#530
20130059388
2013-03-07

METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS

#531
20130059362
2013-03-07

BIOSENSORS COMPRISING PROTEIN-BINDING DOMAINS AND FLUORESCENT PROTEINS

#532
20130045505
2013-02-21

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#533
20130012690
2013-01-10

METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS

#534
20130011497
2013-01-10

Protein arginine N-methyltransferase-5 method of cancer treatment

#535
20130005666
2013-01-03

Reporter system for high throughput screening of compounds and uses thereof

#536
20120322104
2012-12-20

SYSTEMS AND METHODS FOR PROTEIN PRODUCTION

#537
20120321639
2012-12-20

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

#538
20120283411
2012-11-08

METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

#539
20120271036
2012-10-25

Solution Assay and High Through-Put Screen to Probe Interaction Between Human Cullin-Ring Ligase Complex and HIV-VIF Protein

#540
20120270273
2012-10-25

Transcription activator-like effectors

#541
20120246747
2012-09-27

RNA-INTERFERENCE BY SINGLE-STRANDED RNA MOLECULES

#542
20120238509
2012-09-20

UROCORTIN 2 ANALOGS AND USES THEREOF

#543
20120204282
2012-08-09

METHODS AND COMPOSITIONS FOR TREATING OCCULAR DISORDERS

#544
20120185970
2012-07-19

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#545
20120178163
2012-07-12

Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same

#546
20120172311
2012-07-05

Peptidomimetic macrocycles

#547
20120159661
2012-06-21

T-Bet Compositions and Methods of Use Thereof

#548
20120156305
2012-06-21

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

#549
20120142100
2012-06-07

Inhibitors of heat shock RNA

#550
20120134969
2012-05-31

PHARMACEUTICAL COMPOSITION CONTAINING NUCLEAR FACTOR INVOLVED IN PROLIFERATION AND DIFFERENTIATION OF CENTRAL NEURONAL CELLS

#551
20120129254
2012-05-24

Inducible expression system transcription modulators comprising a distributed protein transduction domain and methods for using the same

#552
20120128677
2012-05-24

Pancreatic cancer targets and uses thereof

#553
20120117672
2012-05-10

Isolation and growth of stem cells from hemangiomas

#554
20120114700
2012-05-10

LAT adapter molecule for enhanced T-cell signaling and method of use

#555
20120114619
2012-05-10

PROTEIN WITH PROMOTING EFFECTS FOR AXONAL GROWTH OF NEURONS OF CENTRAL NERVOUS SYSTEM

#556
20120100592
2012-04-26

Pipemidic acid derivative autotaxin inhibitors

#557
20120100561
2012-04-26

A PKN3/RHOC MACROMOLECULAR COMPLEX AND METHODS OF USE THEREFOR

#558
20120094293
2012-04-19

PGC-1β, a novel PGC-1 homologue and uses therefor

#559
20120088902
2012-04-12

METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

#560
20120087929
2012-04-12

VEGF antagonist formulations for intravitreal administration

#561
20120079611
2012-03-29

TL1A model of inflammation fibrosis and autoimmunity

#562
20120063994
2012-03-15

RTEF-1 variants and uses thereof

#563
20120052080
2012-03-01

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

#564
20120030780
2012-02-02

TARGETING OF SALL4 FOR THE TREATMENT AND DIAGNOSIS OF PROLIFERATIVE DISORDERS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME (MDS)

#565
20120028821
2012-02-02

Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides

#566
20110319479
2011-12-29

POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA

#567
20110319478
2011-12-29

Compositions to Treat Cardiac Pacing Conditions

#568
20110311475
2011-12-22

MEANS AND METHOD FOR THE TREATMENT OF ANTIBODY DEFICIENCY DISEASES BASED ON IL-21 AND IL-21 VARIANTS

#569
20110306125
2011-12-15

Protein Expression Methods

#570
20110305741
2011-12-15

Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis

#571
20110301568
2011-12-08

Systems and Methods to Treat Cardiac Pacing Conditions

#572
20110300107
2011-12-08

Methods for treating cardiac pacing conditions

#573
20110293599
2011-12-01

METHOD FOR MODULATING MUSCLE DIFFERENTIATION OR REGENERATION

#574
20110280835
2011-11-17

Commensal bacteria as signal mediators within a mammalian host

#575
20110269695
2011-11-03

NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING SAME

#576
20110268748
2011-11-03

NURR-1 Interacting Protein (NuIP)

#577
20110263831
2011-10-27

Nuclear factor κB inducing factor

#578
20110257601
2011-10-20

VEGF antagonist formulations for intravitreal administration

#579
20110245471
2011-10-06

Nuclear factor κB inducing factor

#580
20110189142
2011-08-04

Senescene Cells and Methods For Its Production

#581
20110183923
2011-07-28

PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME

#582
20110182867
2011-07-28

Modulation of BCL11A for treatment of hemoglobinopathies

#583
20110151478
2011-06-23

TRANSCRIPTIONAL BIOMARKERS AND METHODS FOR DETECTING AND ISOLATING CANCER CELLS IN BODY FLUIDS AND TISSUE SPECIMENS

#584
20110136260
2011-06-09

Snapin and methods for regulation of microtubule assembly and dendrite growth and branching

#585
20110111979
2011-05-12

Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms

#586
20110105718
2011-05-05

Nel-related type 1 polypeptide

#587
20110098227
2011-04-28

Soluble notch-based substrates for gamma secretase and methods and compositions for using same

#588
20110081656
2011-04-07

Methods of identifying compounds that bind TANGO240

#589
20110065649
2011-03-17

Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation

#590
20110065178
2011-03-17

DENDRITIC CELL POTENTIATION

#591
20110055942
2011-03-03

Single domain TDF-related compounds and analogs thereof for use in treating a tissue differentiation factor related disorder

#592
20110052614
2011-03-03

STAT3 EPITOPE PEPTIDES

#593
20110035817
2011-02-10

SIVA 3, its preparation and use

#594
20110014275
2011-01-20

Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma

#595
20110010805
2011-01-13

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#596
20100333233
2010-12-30

Cottonwood Growth eIF-5A

#597
20100333218
2010-12-30

TRANSGENIC PROTEINS FROM MULTI-GENE SYSTEMS, METHODS, COMPOSITIONS, USES AND THE LIKE RELATING THERETO

#598
20100330038
2010-12-30

Methods for expressing proteins in axons

#599
20100317594
2010-12-16

Methods for treating breast cancer using NRIF3 related molecules

#600
20100298226
2010-11-25

POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA